Palo Alto reported the results of its fiscal Q2 last evening. The headline numbers were basically in line with expectations. The guidance…not so much. The shares are down by 24% as I write this. There have been multiple downgrades, and almost all analysts are reducing their price targets. And the malaise in Palo Alto shares…
We had the opportunity to sell our Perion position this morning as the shares reacted to news of a $60 million buy back. Our sale price for $24.41. This netted $16,955. Owning Perion shares has been less than a pleasant experience. The shares are down more than 30% since we entered the position. We redeployed some of…
ZoomInfo: Some very visible green shoots but there is still a bit of frost in the air We don’t own ZI shares in the high growth portfolio; we did however recommend the shares at the start of this year. I won’t go into a detailed review of the financials that the company reported. For the…
Summary Samsara shares have soared 150% since I wrote about the company 12 months ago. The company has seen exceptional operational performance, with sales growth, new customer acquisition, and profitability. The company has notable competitive advantages when selling to enterprise customers. The company has broadened its customer base to beyond trucking and its equipment monitoring…
Dynatrace and Affirm – The opportunities are substantial I often tell subscribers and others that trying to trade earnings releases is a fool’s errand. I have tried to provide advice to a variety of clients for many years. I hope that I can share some of the experiences that I have had. An institutional sales…
Sale of 320 shares of Datadog @ $136.59; Purchase of 1000 shares of UiPath @ $25.09; Purchase of 200 shares of Affirm @ $45.59 We made some portfolio changes this morning. We sold about 1/2rd of our DDOG position as it spiked into the opening. The shares are close to their yearly high. The company is…
Confluent and Perion Yesterday two of our portfolio companies reported. One did well; the other result was a disappointment. At the moment, we are not taking any action on either stock in our high growth portfolio. That said, the forecast growth projected by Perion makes it difficult to hold in a high growth portfolio. On…
Purchase of 400 shares of Confluent This morning we bought 400 shares of Confluent bringing our holding in the high growth portfolio to 1200 shares or about a 3% weighting. We paid $23.49 for the shares, and the total cost of the transaction was $9410. This brought our current margin balance to $209,335. Confluent is…
Summary The best strategy to invest in the AI revolution is to focus on the pick and shovel vendors in the space. These companies serve as toll takers on the road to the deployment of AI based applications. AI needs lots of storage and thus we recommend shares of Pure. AI needs unified storage/compute and…
Sale of 200 shares of Crowdstrike and 250 shares of Monday.com-entire position. Purchase of 400 shares of CFLT; 300 shares of PCOR; 200 shares of AFRM; 600 shares of SentinelOne; and 200 shares of GLBE I started 2024 thinking there would be a few weeks of consolidation after the strong run at the end of 2023. The…